Elizabeth David

Dr. Elizabeth David


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Annals of Palliative Medicine
Verified
Journal Article
Closed access
PDF file
SSSamantha Saravana-Bawan
Samantha Saravana-Bawan
EDElizabeth David
Elizabeth David
ASArjun Sahgal
Arjun Sahgal
ECEdward Chow
Edward Chow
Multiple new options are available in the palliation of bone metastases. Most of these techniques can be used in conjunction with radiation therapy either before or after and are now giving patients who have reached dose limitations new options. These techniques can also be used with vertebroplasty (VP) to increase structural stability post tumor ablation. Localized percutaneous treatment in the bone such as thermal [radiofrequency ablation (RFA)] and light [photodynamic therapy (PDT)] have been used to destroy tumor prior to injection with cement. This educational review will discuss the safety profile, technique and indications for emerging technology in the area of locoregional treatment of bone metastases in conjunction with vertebral augmentation. It will not delve comprehensively into conventional lines of treatment where indications and outcomes have already been well established.

1 April 2017 in Annals of Palliative Medicine
Verified
Journal Article
Closed access
PDF file
EDElizabeth David
Elizabeth David
SKSagi Kaduri
Sagi Kaduri
AYAlbert Yee
Albert Yee
ECEdward Chow
Edward Chow
ASArjun Sahgal
Arjun Sahgal
RHRamez Hanna
Ramez Hanna
Background: To assess the safety and clinical outcomes of bipolar radiofrequency ablation (RFA) assisted vertebroplasty (VP) and osteoplasty (OP) in pathological and insufficiency fractures. The insufficiency fractures were in patients who sustained demineralization secondary to cancer treatment. Methods: Patients referred for symptomatic malignant or insufficiency fractures for VP or OP from January 2011 to May 2015 were retrospectively reviewed. Bipolar RFA was performed (Osteocool RF ablation system, Baylis Medical) reaching a constant temperature of 70 °C over 7 to 15 minutes followed by cement injection. Clinical outcomes were evaluated by review of the electronic medical record (EMR). Radiological outcomes were assessed with CT. Pre and post procedural pain scores were also documented for the RFA subset, primarily to see if there were any adverse effects when using RFA on pain relief. Results: Twenty-six patients in the study were treated with the RFA assisted technique. These contributed to 4 OPs and 35 VP levels. Of these four VP levels were insufficiency fractures. All were technically successful without morbidity or mortality. Fifty-six patients were treated with a non RFA assisted technique. All these were VPs and 142 levels were treated in total. Two levels in this subset were insufficiency fractures. All were technically successful without morbidity or mortality. There was a significantly reduced rate of posterior and venous cement leaks when RFA was used prior to VP. There was no difference in the rate of leakage into the disc spaces when comparing RFA assisted to the conventional technique. Pain scores in the RFA assisted group decreased significantly post procedure with no unanticipated neuropathic events. Conclusions: RFA assisted VP and OP using a bipolar device is safe and allows for controlled injection of cement into a preformed thermal cavity with a significant decrease in venous and posterior cement leaks. Rate of cement leakage into the disc spaces was unaffected.

1 July 2012 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
ENEdmund H. Ng
Edmund H. Ng
JCJules Comin
Jules Comin
EDElizabeth David
Elizabeth David
RPRobyn Pugash
Robyn Pugash
GAGanesan Annamalai
Ganesan Annamalai

8 April 2021 in Current Opinion in Supportive & Palliative Care
Verified
Journal Article
Closed access
HBHadas Benhabib
Hadas Benhabib
HMHarley Meirovich
Harley Meirovich
EDElizabeth David
Elizabeth David
Purpose of review: Bone metastases are responsible for considerable morbidity, which can significantly limit a patient's quality of life. This article aims to review minimally invasive, image-guided locoregional treatments for symptomatic bone metastases as an adjunct to conventional treatment modalities. Recent findings: Conservative therapy and radiation therapy (RT) can be effective at addressing pain, however, they require time to achieve optimal efficacy and do not address the instability and progressive collapse of pathological fractures. Vertebral and pelvic augmentation with cement enhances structural stability and can prevent progressive collapse and deformity. Ablative therapies, including radiofrequency ablation (RFA), cryoablation, and photodynamic therapy (PDT), induce cellular destruction of tumor tissue. RFA and PDT can be combined with cement augmentation in a single sitting. Summary: Minimally invasive image-guided treatments can provide rapid pain relief, enhance mechanical stability, and improve quality of life. These treatments are associated with low complication rates and are suitable for frail patients. They can be used as companion procedures to conventional treatments, or function as an alternative for patients with radioresistant biologies or those with dose limitations from prior RT sessions.

6 July 2021 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
GMGilbert Maroun
Gilbert Maroun
RPRobyn Pugash
Robyn Pugash
HMHarley Meirovich
Harley Meirovich
EDElizabeth David
Elizabeth David

6 January 2022 in Current Oncology
Verified
Journal Article
Open access
PDF file
NVNicolas Voizard
Nicolas Voizard
TNTiffany Ni
Tiffany Ni
AKAlex Kiss
Alex Kiss
RPRobyn Pugash
Robyn Pugash
MRMichael J. Raphael
Michael J. Raphael
EDElizabeth David
Elizabeth David
The aim of this study was to examine the safety and efficacy of 40 µm and 75 µm calibrated irinotecan-eluting beads (DEBIRI-TACE) for the treatment of colorectal cancer metastases. We conducted a retrospective review of 36 patients with unresectable liver metastases from colorectal cancer who were treated with DEBIRI-TACE between 2017 to 2020. Patients who received at least one session of DEBIRI were included in our analysis. A total of 105 DEBIRI sessions were completed. 86% of patients (n = 31) underwent one round of treatment, 14% of patients (n = 5) underwent two distinct rounds of treatment. The majority of patients were discharged the next day (92%, n = 33 patients) with no 30-day post-DEBIRI mortality. Five high-grade adverse events occurred, including longer stay for pain management (n = 2), postembolization syndrome requiring readmission (n = 2), and liver abscess (n = 1). The average survival from diagnosis of metastatic disease was 33.3 months (range 11–95, median 28). Nine of 36 patients are still alive (December 2020) and have an average follow-up time of 36.8 months from T0 (range 12–63, median 39). Small particle DEBIRI is safe and well-tolerated in the salvage setting, with outcomes comparable to that of larger bead sizes.